Navigation Links
Protalex, Inc. Announces Screening Of First Patients In U.S. For New Trial Of PRTX-100 In Patients With Active Rheumatoid Arthritis
Date:11/8/2012

SUMMIT, N.J., Nov. 8, 2012 /PRNewswire/ -- Protalex, Inc. (OTCBB: PRTX), a clinical stage biopharmaceutical company, today announced that it has begun screening patients at sites in the U.S. for its new multicenter Phase 1b randomized, multiple-dose, dose-escalation study of PRTX-100 in adults with active rheumatoid arthritis (RA). Protalex is focused on the development of a class of drugs designed to treat autoimmune and inflammatory diseases including RA.

The primary objective of this Phase 1b study of PRTX-100 will be to further assess the safety and tolerability of intravenous PRTX-100 administered weekly over 5 weeks in patients with active rheumatoid arthritis on methotrexate therapy. The secondary objectives include determining the effects of PRTX-100 on measures of disease activity, assessing the immunogenicity and evaluating the pharmacokinetic (PK) parameters after repeated doses, and determining possible relationships between the immunogenicity of PRTX-100 and safety, PK and efficacy parameters.

The sequential dose escalation phase of this Phase1b study will randomize up to 40 patients into the dose escalation cohorts starting at 1.50 ug/kg PRTX-100 or placebo, followed by up to 12 additional randomized patients for cohort expansion. Enrollment is expected to take place at study sites in both the U.S. and South Africa.

A more complete description of Protalex, its business and this study can be found in the reports it periodically files with the Securities and Exchange Commission (SEC) pursuant to the Securities Exchange Act of 1934, as amended, including its Annual Report on Form 10-K filed on August 29, 2012, and its Quarterly Report on Form 10-Q filed on October 12, 2012 which are available at the SEC's website at www.sec.gov

About Protalex, Inc.

Protalex, Inc. is a clinical stage biopharmaceutical company focused on the development of a class of biopharmaceutical drugs for tr
'/>"/>

SOURCE Protalex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Harwood Feffer LLP Announces Investigation of DUSA Pharmaceuticals, Inc.
2. ActiveCare Announces Record Revenue For Quarter Ending June 30, 2012
3. Echo Therapeutics Announces Third Quarter 2012 Financial Results
4. Concord Medical Announces Change to Third Quarter Financial Results Date to November 20, 2012
5. Winner Medical Announces Mailing of Definitive Proxy Materials for Special Meeting of Shareholders
6. Genoa Pharmaceuticals announces $1.2M Financing
7. Genomic Health Announces Third Quarter 2012 Financial Results and Business Progress
8. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
9. Life Technologies Announces Next-Gen Digital PCR Instrument Designed for Widespread Adoption
10. Blue Belt Technologies Announces First United Kingdom-Based NavioPFS Unicondylar Knee Replacement Surgery
11. IRIDEX Announces Tender Offer to Purchase up to 487,500 Shares of its Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... 2015  Accuray Incorporated (Nasdaq: ARAY ) ... with MIM Software Inc. to further develop adaptive ... ® product portfolios. The new software solution ... is Accuray,s second collaboration with MIM; the previous ... iPad-based treatment plan review capability, PlanTouch™. ...
(Date:4/30/2015)... DIEGO, April 30, 2015  Tandem Diabetes Care ® , ... manufacturer of the t:slim ® and t:flex™ Insulin Pumps, ... 31, 2015. In comparing the first quarter ... Sales grew 53 percent to $12.3 million from $8.1 million ... pumps from 1,723 pumps "Our investment in resources ...
(Date:4/30/2015)... LA JOLLA, Calif. , April 30, 2015 /PRNewswire/ ... a biopharmaceutical company leading the discovery and development of ... report financial results and highlights for the quarter ended ... the U.S. financial markets close. Regulus ... May 7, 2015, at 5:00 pm Eastern Daylight Time ...
Breaking Medicine Technology:Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 2Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 3Tandem Diabetes Care Reports First Quarter 2015 Financial Results 2Tandem Diabetes Care Reports First Quarter 2015 Financial Results 3Tandem Diabetes Care Reports First Quarter 2015 Financial Results 4Tandem Diabetes Care Reports First Quarter 2015 Financial Results 5Tandem Diabetes Care Reports First Quarter 2015 Financial Results 6Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call 3
... Aug. 18, 2011 Insource Spend Management Group, ... services, announced it has hit a milestone of ... clients.  Many Fortune 500 clients have individually saved ... of software, analytics and expert negotiation. Shippers across ...
... Chief Financial Officer of Chembio Diagnostics, Inc. (OTCQB: CEMI) (OTC.BB: ... is among the recipients of the "2011 CFO of the ... LIBN ).  A total of 27 CFOs were awarded the ... of two CFOs of a public company with revenue under ...
Cached Medicine Technology:Insource Saves Clients Over $1 Billion on Parcel Shipping 2Chembio Diagnostics' CFO Richard J. Larkin Among the Recipients of "2011 CFO of the Year" Award from Long Island Business News 2Chembio Diagnostics' CFO Richard J. Larkin Among the Recipients of "2011 CFO of the Year" Award from Long Island Business News 3
(Date:5/2/2015)... 03, 2015 As one of only ... prestigious Safety and Health Achievement and Recognition Program (SHARP) ... be chosen by the Illinois Department of Labor to ... and maintained SHARP certification by the Occupational Safety and ... Essentra has continued to meet or exceed all of ...
(Date:5/2/2015)... 2015 ProText Kinetic 2 is a set ... Cut Pro X. ProText Kinetic 2 features 40 ... Cut Pro X . Easily create interactive text videos ... Studios' ProText Kinetic 2. , Using ProText Kinetic is as ... ProText Kinetic presets in the FCPX timeline. Playback the ...
(Date:5/2/2015)... 02, 2015 On Tuesday April 7th, ... (ELCH) gathered to celebrate improvements in patient care. In ... Partners (RVHP), had zero acquired ventilator associated infections, zero ... infections. ELCH was also recently named a Top Performer ... at ELCH credited the teamwork of staff from all ...
(Date:5/2/2015)... success that Veatch Dental Consulting has had over the years, ... Shields to the team. With Neida and Alex on board, ... working with dentists to ensure their success. , Neida Miranda ... She was certified as dental assistant from Texas State Technical ... the importance of oral hygiene to patients, Neida was moved ...
(Date:5/1/2015)... Jusuru International has been awarded the prestigious 2015 ... flagship nutritional supplement, Liquid BioCellâ„¢ Life, and the relaunch ... logo, new packaging, new products, and new messaging. ... and promote programs that serve as examples of direct ... International for their outstanding accomplishments and contributions to direct ...
Breaking Medicine News(10 mins):Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3Health News:Pixel Film Studios Announced the Release of Protext Kinetic 2 for FPCX. 2Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2Health News:Veatch Dental Consulting Services Welcomes New Team Members 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5
... the forefront of HIV prevention research will be taking center ... L. Lawrence Convention Center in Pittsburgh May 22-25. M2010 ... community advocates and experts in global health who are working ... of the world. Nearly 1,000 participants from 47 countries will ...
... controlled severe disease using less medication , MONDAY, May ... be a mouse click away, Dutch researchers report. , ... program maintained long-term control of severe asthma but needed ... do so, the study found. , "We know that ...
... Fighting cock energy has seen an explosive ... brand and the name to get an instant smile and chuckle. What was the first thing ... ... was born on the cusp of the energy drink boom that has come to fruition through the ...
... , ... invited to attend an EMR info session on Thursday May 27, 2010 at the MacLaren ... & cheese reception, presentation, and EMR demonstration. , ... Markham, Ontario (PRWEB) May 17, 2010 -- Barrie area physicians are invited ...
... Dog bites represent a tiny ... less severe than injuries we suffer from other common enjoyments. The good news about dog bites ... ... humans and 75 million dogs in the U.S. The majority of dog owners view their dogs ...
... ... pet owners that small pets are fragile and susceptible to injury. , ... (Vocus) May 17, 2010 -- Trupanion, a ... beneficial for their pets. A small Yorkshire Terrier, Felix, is insured with Trupanion and recently ...
Cached Medicine News:Health News:Press briefings at International Microbicides Conference May 22-25 2Health News:Press briefings at International Microbicides Conference May 22-25 3Health News:Press briefings at International Microbicides Conference May 22-25 4Health News:Press briefings at International Microbicides Conference May 22-25 5Health News:Web-Based Program Can Boost Asthma Care 2Health News:Unique Marketing Approach to the Energy Drink Market Brings Explosive Response 2Health News:Good News About Dog Bites and How to Make it Better 2Health News:Good News About Dog Bites and How to Make it Better 3Health News:Trupanion Emphasizes the Importance of Pet Insurance for Small Pets 2
Super High Density, 120 field of view, angled handle, multi-frequency, convex endovaginal transducer....
Super High Density, 120 degree field of view, straight handle, multi-frequency, convex endovaginal transducer....
Visualize the prostate in both transverse and longitudinal planes....
Prostate biopsy transducer....
Medicine Products: